503 related articles for article (PubMed ID: 17109493)
1. Caenorhabditis elegans: a versatile platform for drug discovery.
Artal-Sanz M; de Jong L; Tavernarakis N
Biotechnol J; 2006 Dec; 1(12):1405-18. PubMed ID: 17109493
[TBL] [Abstract][Full Text] [Related]
2. Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.
Nass R; Merchant KM; Ryan T
Mol Interv; 2008 Dec; 8(6):284-93. PubMed ID: 19144901
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery: here comes the worm.
Ségalat L
ACS Chem Biol; 2006 Jun; 1(5):277-8. PubMed ID: 17163755
[TBL] [Abstract][Full Text] [Related]
4. [Caenorhabditis elegans: a powerful tool for drug discovery].
Jia XH; Cao C
Yao Xue Xue Bao; 2009 Jul; 44(7):687-94. PubMed ID: 19806904
[TBL] [Abstract][Full Text] [Related]
5. Invertebrate animal models of diseases as screening tools in drug discovery.
Ségalat L
ACS Chem Biol; 2007 Apr; 2(4):231-6. PubMed ID: 17455900
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans.
Burns AR; Kwok TC; Howard A; Houston E; Johanson K; Chan A; Cutler SR; McCourt P; Roy PJ
Nat Protoc; 2006; 1(4):1906-14. PubMed ID: 17487175
[TBL] [Abstract][Full Text] [Related]
7. Modeling human diseases in Caenorhabditis elegans.
Markaki M; Tavernarakis N
Biotechnol J; 2010 Dec; 5(12):1261-76. PubMed ID: 21154667
[TBL] [Abstract][Full Text] [Related]
8. Endocrine targets for pharmacological intervention in aging in Caenorhabditis elegans.
Gill MS
Aging Cell; 2006 Feb; 5(1):23-30. PubMed ID: 16441840
[TBL] [Abstract][Full Text] [Related]
9. Non-developmentally programmed cell death in Caenorhabditis elegans.
Kourtis N; Tavernarakis N
Semin Cancer Biol; 2007 Apr; 17(2):122-33. PubMed ID: 17196824
[TBL] [Abstract][Full Text] [Related]
10. Chemistry and the worm: Caenorhabditis elegans as a platform for integrating chemical and biological research.
Hulme SE; Whitesides GM
Angew Chem Int Ed Engl; 2011 May; 50(21):4774-807. PubMed ID: 21500322
[TBL] [Abstract][Full Text] [Related]
11. Tat-mediated protein delivery in living Caenorhabditis elegans.
Delom F; Fessart D; Caruso ME; Chevet E
Biochem Biophys Res Commun; 2007 Jan; 352(3):587-91. PubMed ID: 17141180
[TBL] [Abstract][Full Text] [Related]
12. The versatile worm: genetic and genomic resources for Caenorhabditis elegans research.
Antoshechkin I; Sternberg PW
Nat Rev Genet; 2007 Jul; 8(7):518-32. PubMed ID: 17549065
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.
Outeiro TF; Giorgini F
Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706
[TBL] [Abstract][Full Text] [Related]
15. C. elegans: an invaluable model organism for the proteomics studies of the cholesterol-mediated signaling pathway.
Paik YK; Jeong SK; Lee EY; Jeong PY; Shim YH
Expert Rev Proteomics; 2006 Aug; 3(4):439-53. PubMed ID: 16901202
[TBL] [Abstract][Full Text] [Related]
16. Caenorhabditis elegans as a chemical screening tool for the study o f neuromuscular disorders. Manual and semi-automated methods.
Giacomotto J; Ségalat L; Carre-Pierrat M; Gieseler K
Methods; 2012 Jan; 56(1):103-13. PubMed ID: 22041718
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging strategies for drug discovery and development.
Gross S; Piwnica-Worms D
Curr Opin Chem Biol; 2006 Aug; 10(4):334-42. PubMed ID: 16822702
[TBL] [Abstract][Full Text] [Related]
18. Non-apoptotic cell death in Caenorhabditis elegans.
Vlachos M; Tavernarakis N
Dev Dyn; 2010 May; 239(5):1337-51. PubMed ID: 20108319
[TBL] [Abstract][Full Text] [Related]
19. A small-molecule screen in C. elegans yields a new calcium channel antagonist.
Kwok TC; Ricker N; Fraser R; Chan AW; Burns A; Stanley EF; McCourt P; Cutler SR; Roy PJ
Nature; 2006 May; 441(7089):91-5. PubMed ID: 16672971
[TBL] [Abstract][Full Text] [Related]
20. Exploiting complexity and the robustness of network architecture for drug discovery.
Hellerstein MK
J Pharmacol Exp Ther; 2008 Apr; 325(1):1-9. PubMed ID: 18202293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
